newsfilter
← Latest News
FDA Approved Drugs·

Approval of Naproxen Sodium, Anda #202807 (Labeling)

Approval Date: 09/19/2023; Drug Name: Naproxen Sodium, Anda #202807; Active Ingredients: NAPROXEN SODIUM; Company: Catalent; Submission Status: Approval; Submission Classification: Labeling; Application Number: 202807

Company
CATALENT
Keywords
CATALENT